Efficacy and Safety of Dabigatran Compared to Warfarin for 6-Month Treatment of Acute Symptomatic Venous Thromboembolism - RE-COVER

Description:

Dabigatran is an orally active direct thrombin inhibitor, and has been evaluated in a number of settings including prevention of deep vein thrombosis (DVT) in patients undergoing orthopedic surgery. Recently, it was found that dabigatran 150 mg bid had superior efficacy with similar safety when compared with warfarin, when used in preventing stroke in patients with atrial fibrillation. The current trial sought to study the safety and efficacy of dabigatran compared with warfarin for the treatmen...